BioSpace News Archive

Number one doctor recommended blood pressure brand supports AHA and AMA program targeting uncontrolled high blood pressure [13-May-2019] LAKE FOREST, Ill. , May 13, 2019 /PRNewswire/ -- Omron Healthcare, Inc., the global leader in personal heart health and wellness technology, has donated a range of blood pressure monitors to support and raise awareness for Target: B

AirXpanders, Inc. announced that the company has submitted a Special 510 pre-market notification to the US Food and Drug Administration for a Smooth Shell version of the AeroForm Tissue Expander System.

Tandem Diabetes Care, Inc. announced that management will present a Company update at the following upcoming investor conferences

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York.

The Chartis Group has been named to Modern Healthcare’s Best Places to Work in Healthcare for 2019.

A settlement has been reached in a class action lawsuit on behalf of all Out-of-Network Chiropractic Providers who provided clinical services to a Cigna Plan member, whose claims for reimbursement of such services were denied in part or in whole.

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group, are taking action to help people affected by recent flooding across parts of Louisiana.

Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer’s and other degenerative diseases, today announced the closing of its initial public offering of 4,412,000 shares

Ed Evarts, leadership development coach, management consulting for 3D Leadership Group (http://3dleadershipgroup.com), a Boston-based leadership development firm, recently presented at MAGI’s Clinical Research Conference – 2019 East, which was held May 5-8 at the Sheraton Boston Hotel in Boston

Milestone Pharmaceuticals Inc. announced the closing of its previously announced initial public offering of 5,500,000 of its common shares at a public offering price of $15.00 per share.